Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity

In Vivo

Volumn 21, Issue 2, 2007, Pages 389-395

  Hussein, A ^a   Mioglou Kalouptsi, E ^b   Papageorgiou, A ^c   Karapidaki, I ^b   Iakovidou Kritsi, Z ^b   Lialiaris, Th ^d   Xrysogelou, E ^c   Camoutsis, Ch ^a   Mourelatos, D ^b  

^a UNIVERSITY OF PATRAS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Theagenion Anticancer Institute   (Greece)

^d DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Antitumor effect; Cytogenetic effect; L1210; Nitrisourea ester; P388; PRI; SCEs

Indexed keywords

17 BETA [N (2 CHLOROETHYL) N NITROSOCARBAMOYL]ALANYL] 3 AZA A HOMO 4A ANDROSTEN 5 ONE; 17 BETA [N [N (2 CHLOROETHYL) N NITROSOCARBAMOYL]ALANYL] 17 METHYLANDROST 4 EN 3 ONE; 17 BETA [N [N (2 CHLOROETHYL) N NITROSOCARBAMOYL]ALANYL] 5A ANDROSTAN 3 ONE; 17 BETA [N [N (2 CHLOROETHYL) N NITROSOCARBAMOYL]ALANYL]ANDROST 4 EN 3 ONE; 3 BETA [N [N (2 CHLOROETHYL) N NITROSOCARBAMOYL]ALANYL] 5A ANDROSTAN 17 ONE; 3 BETA [N [N (2 CHLOROETHYL) N NITROSOCARBAMOYL]ALANYL]ANDROST 5 EN 17 BETA ACETAMIDE; 3 BETA [N [N (2 CHLOROETHYL) N NITROSOCARBAMOYL]ALANYL]ANDROST 5 EN 17 ONE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; NITROSOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBAMOYLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOGENETICS; DRUG DOSE COMPARISON; ESTERIFICATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHATIC LEUKEMIA; NONHUMAN; SISTER CHROMATID EXCHANGE; STRUCTURE ACTIVITY RELATION;

EID: 34047205929     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wall ME, Abemethy SG, Carroll JFI and Taylor DJ: The effects of some steroidal alkylating agents in experimental animal mammary tumor and leukemia systems. J Med Chem 12: 810-818, 1969.
2. Wampler Gl and Catsoulacos P: Antileukemic effect of homo-aza-steroidal-ester of [p-[bis(2-chloroethyl)amino] acetic acid. Cancer Treat Rep 61: 37-41, 1977.
3. Catsoulacos P, Camoutsis C and Wampler GL: Effect of Δ5 homo-aza-steroidal ester in P388 and L1210 murine leukemias. Oncology 39: 59-60, 1982.
4. Catsoulacos P, Politis D and Wampler GL: A new steroidal alkylating agent with improved activity in advanced murine leukemias. Cancer Chemother Pharmacol 3: 67-70, 1979.
5. Catsoulacos P and Wampler GL: Activity of 3β-hydroxy-13α-amino-13, 17-seco-5α-androstan-17-oic-13, 17-lactam(p-bis(chloroethyl)amino-phenyl) acetate (NSC-290205) in murine solid tumors. Oncology 39: 109-112, 1982.
6. Catsoulacos P: Further studies on the antineoplastic activity of 3β-hydroxy-13α-amino-13, 17-seco-5α-androstan-17-oic-13, 17-lactam(p-bis(chloroethyl) amino-phenyl) acetate (NSC-290205). Cancer Lett 22: 199-202, 1984.
7. Catsoulacos P: Activity of 3β-hydroxy-13α-amino-13, 17-seco-5α-androstan-17-oic-13, 17-lactam(p-bis(chloroethyl) amino-phenyl) acetate (NSC-290205) on experimental tumor and leukemia systems. Oncology 40: 290-292, 1983.
8. Catsoulacos P and Catsoulacos D: Antitumor activity of homo-aza-steroidal esters of p-N-N-bis(2-chloroethyl) amino phenoxy acetic acid. Anticancer Res 13: 1203-1208, 1993.
9. Serrou B, Schein PS and Imbach JL: Nitrosoureas in cancer treatment. Inserm Symposium No 19, Elsevier/North Holland, Biomedical Press, Amsterdam 1981.
10. Prestayko AW, Crooke ST, Baker LH, Carter SK and Schein PS: Nitrosoureas: Current status and new developments. Academic Press, New York, 1981.
11. Goto K, Maeda S, Kano Y and Sugiyama T: Factors involved in differential Giemsa staining of sister chromatids: Chromosoma 66: 351-359, 1978.
12. Goldin A, Sofina Z and Cyrkin A: Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations. Natl Cancer Inst Monogr 55: 25-26, 1980.
13. Weincke KJ and Weimels J: Genotoxicity of 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Mut Res 339: 91-119, 1995.
14. Kohn WK: Interstrand cross-linking of DNA by 1, 3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas. Cancer Res 37: 1450-1454, 1977.
15. Papageorgiou A, Boutis L, Mourelatos D, Dozi-Vassiliades J, Camoutsis C and Catsoulacos P: A comparative study of the cytogenetic and antineoplastic effects induced by modified steroidal derivatives of b-bis(2-chloroethyl)aminophenyl propenoic acid in human lymphocytes in vitro and in three transplantable tumors in vivo. J Occup Med Toxic 1, 2: 199-208, 1992.
16. PMID: 12132876 [PubMed - indexed for MEDLINE] Camoutsis C, Catsoulacos D, Karayianni V, Papageorgiou A, Mioglou E, Kritsi Z and Nikolaropoulos S: Comparative study of sister chromatide exchange induction and antitumor effects by homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino] phenyl]butyric acid. Cancer Detect. Prev 25(6): 558-564, 2001.
17. Karayianni V, Mioglou E, Iakovidou Z, Mourelatos D, Fousteris M, Koutsourea A, Arsenou E and Nikolaropoulos S: A new approach for evaluation in vivo anti-leukemic activity using the SCE assay. An application on three newly synthesized anti-tumor steroidal esters. Mutat Res 535: 79-86, 2003.
18. Pertou C, Mourelatos D, Mioglou E, Dozi-Vassiliades J and Catsoulacos P: Effects of alkylating antineoplastics alone or in combination with 3-aminobenzamide on genotoxicity, antitumor activity and NAD levels in human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo. Teratog Carcinog Mutagen 10: 321-33, 1990.
19. Christmann M, Tomicic MT, Roos WP and Kaina B: Mechanisms of human DNA repair: an update. Toxicology 193: 3-34, 2003.